These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33847414)

  • 21. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
    Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
    PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
    Gran G; Aßmus J; Dyrhol-Riise AM
    BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
    Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
    Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting.
    Mandalakas AM; Kirchner HL; Walzl G; Gie RP; Schaaf HS; Cotton MF; Grewal HM; Hesseling AC
    Am J Respir Crit Care Med; 2015 Apr; 191(7):820-30. PubMed ID: 25622087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
    Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
    J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of single and dual latent tuberculosis screening strategies before biologic and targeted therapy in patients with rheumatic diseases: a retrospective cohort study.
    Tang I; So H; Luk L; Wong V; Pang S; Lao V; Yip R
    Hong Kong Med J; 2020 Apr; 26(2):111-119. PubMed ID: 32245912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
    Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
    Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An outbreak of pulmonary tuberculosis and a follow-up investigation of latent tuberculosis in a high school in an eastern city in China, 2016-2019.
    Fang Y; Ma Y; Lu Q; Sun J; Pei Y
    PLoS One; 2021; 16(2):e0247564. PubMed ID: 33626108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
    Stockbridge EL; Loethen AD; Annan E; Miller TL
    PLoS One; 2020; 15(12):e0243102. PubMed ID: 33270737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions.
    Villa S; Codecasa LR; Faccini M; Pontello MM; Ferrarese M; Castellotti PF; Senatore S; Lamberti A; Mazzola E; Perno CF; Campisi D; Saporiti M; Raviglione MC
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31413161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries.
    Kowada A
    Travel Med Infect Dis; 2016; 14(5):489-498. PubMed ID: 27238907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases.
    Lee CK; Wong SHV; Lui G; Tang W; Tam LS; Ip M; Hung E; Chen M; Wu JC; Ng SC
    J Crohns Colitis; 2018 Jul; 12(8):954-962. PubMed ID: 29757355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a new interferon gamma release assay, in comparison to tuberculin skin tests and quantiferon tuberculosis goldplus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting.
    Benachinmardi K; Sampath S; Rao M
    Int J Mycobacteriol; 2021; 10(2):142-148. PubMed ID: 34558465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neonatal exposure to active pulmonary tuberculosis in a maternity ward: screening and clinical course of a cohort of exposed infants].
    Perry A; Angoulvant F; Chadelat K; De Lauzanne A; Houdouin V; Kheniche A; Lorrot M; Mesples B; Nouyrigat V; Aujard Y; Gaudelus J; Grimprel E; Faye A
    Arch Pediatr; 2012 Apr; 19(4):396-403. PubMed ID: 22377245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance with postexposure screening and treatment of latent tuberculosis infection among healthcare workers in a tertiary care hospital in Saudi Arabia.
    Balkhy HH; Miller TL; Ali S; Nuzzo JB; Kentenyants K; El-Saed A; McNabb SJ
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):176-81. PubMed ID: 24442081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
    Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
    BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of 4 methods for screening of latent tuberculosis infection in patients with chronic inflammatory arthritis under TNFα inhibitors: a 24-month prospective study.
    Gomes CMF; Terreri MT; Moraes-Pinto MI; Pinheiro MM
    Adv Rheumatol; 2021 Nov; 61(1):71. PubMed ID: 34838126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of
    Xu Y; Yang Q; Zhou J; Zhou F; Hezhang Y; Gao Y; Shao L; Shi J; Ruan Q; Zhang W
    Microbiol Spectr; 2022 Apr; 10(2):e0187021. PubMed ID: 35234509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.